Le Travenues Technology Q2 Profit Hits Rs 63 Cr; Shares Allotted

TECHNOLOGY
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Le Travenues Technology Q2 Profit Hits Rs 63 Cr; Shares Allotted

Le Travenues Technology reported a robust turnaround for Q2 ended September 2026, posting a net profit of Rs 63.42 crore against a loss of Rs 3.46 crore in the same period last year. Revenue grew to Rs 320.96 crore. Additionally, the company allotted 173,780 shares under ESOP schemes and reappointed PwC as its internal auditor for FY 2027.

Le Travenues Technology Q2 Profit Reaches Rs 63.42 Crore

Revenue for Q2 stood at Rs 320.96 crore, up from Rs 284.23 crore in the year-ago period.

Reader Takeaway: Strong operational turnaround with significant profit growth, though dilution from ESOP allotment merits close attention.

What just happened

Le Travenues Technology has announced its financial results for the quarter and half-year ended September 30, 2026. The company successfully transitioned from a loss-making position in the previous year to a profit-making one in the current fiscal. Alongside these financial disclosures, the board approved the allotment of 173,780 equity shares to employees exercising stock options. The company also confirmed the reappointment of PricewaterhouseCoopers Services LLP as its internal auditor for the upcoming financial year.

Why this matters

The swing to a net profit of Rs 63.42 crore for the quarter signals stronger operational efficiency and scale compared to the Rs 3.46 crore loss reported in the corresponding period of 2025. With half-year profits climbing to Rs 97.66 crore, the firm is demonstrating sustained growth momentum in its revenue streams. The increase in paid-up capital following the ESOP exercise reflects ongoing incentive programs for its workforce.

What changes now

The company’s paid-up share capital has increased from Rs 44.11 crore to Rs 44.13 crore. Governance remains stable with the continuation of PwC as the internal auditor through March 2027, providing continuity in internal oversight.

What to track next

Investors should monitor whether the current margin expansion can be sustained in subsequent quarters and how the company manages the dilution impact of its ongoing ESOP schemes. Continued growth in revenue from operations will remain the primary metric for tracking market penetration.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.